Evidence map›Paper›PMID 29922968›Full record

ArticleInternational journal of clinical pharmacy2018

Clinical pharmacist interventions in managing drug-related problems in hospitalized patients with neurological diseases.

Mostafa A Sayed Ali, Eman Mohamed Hussein Khedr, Fatma Alzahraa Hassan Ahmed, Nada Nasr Eldin Mohamed

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Pharmacy practice in hospital settings in GCC countries: Pharmacists' medication therapy monitoring activities.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  8. Article
  9. Article
  10. Drug-related problems in hospitalised Parkinson's disease patients in China.European journal of hospital pharmacy : science and practice · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mostafa A Sayed AliDepartment of Clinical Pharmacy, Faculty of Pharmacy, Assiut University, Assiut, 71526, Egypt. mostafa.ali3@pharm.au.edu.eg.ORCID http://orcid.org/0000-0002-5851-5088
Eman Mohamed Hussein KhedrDepartment of Neuropsychiatry, Faculty of Medicine, Assiut University Hospital, 71526 Assiut, Egypt.
Fatma Alzahraa Hassan AhmedDepartment of Neuropsychiatry, Faculty of Medicine, Assiut University Hospital, 71526 Assiut, Egypt.
Nada Nasr Eldin MohamedDepartment of Neuropsychiatry, Faculty of Medicine, Assiut University Hospital, 71526 Assiut, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Drug-related problems (DRPs) are common in hospitalized patients with neurological diseases. Clinical pharmacy services could minimize drug-related harm and improve patient care. Objective To identify common DRPs in neurology and document clinical pharmacists' medication-related interventions. Setting The wards and intensive care unit of the Department of Neurology at Assiut University Hospital. Method Prospective study of clinical pharmacists' interventions during the routine care work of reviewing patients medical charts over a period of 6 months from January to June 2017. Main outcome measure The frequency and severity of DRPs and clinical pharmacists' recommendations. Results Out of 1421 reviewed medications charts, a total of 414 DRPs were detected for 285 admitted patients. The most common DRPs were drug selection problems (36.7%) and dosing errors (27.5%). The majority of DRPs (71.7%) were categorized as causing no patient harm. Clinical pharmacists provided recommendations for the detected problems that ranged from drug monitoring to stop and starting new medicines. About 90% of pharmacists' interventions were accepted by physicians. Poisson regression of factors that may influence the frequency of DRPs revealed significant associations of patient age (p = 0.03) and the number of comorbid diseases (p = 0.01). Conclusions Prescribing errors in neurology inpatient are likely to occur. Clinical pharmacists' interventions assisted in early detection of drug problems and prevention of the consequent patient harms.

Indexed as

PharmacistsAdolescentAdultAgedAged, 80 and overFemaleHospitals, UniversityHumansInpatientsMaleMedication ErrorsMiddle AgedNervous System DiseasesPharmacy Service, HospitalProfessional RoleProspective StudiesClinical pharmacistsDrug-related problemsEgyptHospitalized patientsNeurologyPatient harm

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.